Tert-Butyl Formate

Tert-Butyl Formate

SCHEMBL28277637

CC(C)(C)OC=O.CCC(c1ccc([C@H](C)NC(=O)C(F)(F)F)cc1)N1CCNCC1

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ ACACB O00763 5/20 0.38
▸ CNR1 P21554 1/20 0.37
▸ SLC6A4 P31645 10/20 0.37
▸ SLC6A2 P23975 9/20 0.37
▸ GPR139 Q6DWJ6 1/20 0.35
▸ CYP2D6 P10635 4/20 0.35
▸ KCNH2 Q12809 4/20 0.35
▸ SLC6A3 Q01959 3/20 0.35
▸ OPRD1 P41143 2/20 0.34
▸ CACNA1F O60840 1/20 0.34
▸ CYP3A4 P08684 1/20 0.34
▸ CACNA1D Q01668 1/20 0.34
▸ CACNA1S Q13698 1/20 0.34
▸ CACNA1C Q13936 1/20 0.34
▸ TACR1 P25103 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tert-Butyl Formate SCHEMBL28277635 1.00 ACACB (0.38) ACACBCNR1SLC6A4SLC6A2GPR139
Tert-Butyl Formate SCHEMBL28279069 0.80 SLC6A2 (0.41) SLC6A4SLC6A2CYP2D6KCNH2SLC6A3
Tert-Butyl Formate SCHEMBL28279072 0.80 SLC6A2 (0.41) SLC6A4SLC6A2CYP2D6KCNH2SLC6A3
SCHEMBL19700725 0.80 MAPT (0.45) ACACBCNR1CYP3A4TACR1
SCHEMBL20289586 0.80 MAPT (0.45) ACACBCNR1CYP3A4TACR1
SCHEMBL21378569 0.80 MAPT (0.45) ACACBCNR1CYP3A4TACR1
SCHEMBL21378401 0.78 ACACB (0.41) ACACBCNR1OPRD1TACR1
SCHEMBL21378399 0.78 ACACB (0.41) ACACBCNR1OPRD1TACR1
SCHEMBL28277634 0.78 ACACB (0.41) ACACBCNR1
SCHEMBL20289632 0.71 MAPT (0.44) ACACBCNR1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109311863-A Saltant type IDH1 inhibitor 伊莱利利公司 2019-02-05 — — CN disclosed
Send feedback